Evidence map›Paper›PMID 33584542›Full record

Observational studyFrontiers in endocrinology2020

Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population.

Ana Arnanz, Neelke De Munck, Ibrahim El Khatib, Aşina Bayram, Andrea Abdala, Laura Melado, Barbara Lawrenz, Carol Coughlan, Alberto Pacheco, Juan A Garcia-Velasco and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Ana ArnanzART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Neelke De MunckART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Ibrahim El KhatibART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Aşina BayramART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Andrea AbdalaART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Laura MeladoART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Barbara LawrenzART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Carol CoughlanART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Alberto PachecoIVIRMA, Madrid, Spain.
Juan A Garcia-VelascoIVIRMA, Madrid, Spain.
Human M FatemiART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
IVI Middle East Fertility Clinic · AEUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: The widespread distribution of the Vitamin D (VitD) receptor in reproductive tissues suggests an important role for VitD in human reproduction. The assessment of patient´s VitD is based on the 25-hydroxyvitamin D (25(OH)D) metabolite measurement. However, most of the circulating 25(OH)D is bound to either VitD-binding protein (VDBP) (88%) or albumin (12%) and less than 1% circulates free. Objective: To determine a possible correlation between VitD levels in serum (S) and follicular fluid (FF) and blastocyst ploidy status in patients undergoing infertility treatment. Methods: A prospective observational study was performed including couples planned for preimplantation genetic testing for aneuploidies (PGT-A) from ART Fertility Clinics. Patients were classified according to their 25(OH)D-Serum levels: VitD deficient group <20 ng/ml and insufficient/replete ≥20 ng/ml defined as VitD non-deficient group. Results: Serum samples and 226 FF from individual follicles were collected for 25(OH)D, bioavailable 25(OH)D, free 25(OH)D, and % free 25(OH)D measurement. 25(OH)D-Serum in VitD deficient and non-deficient were 13.2±4.0 ng/ml vs 32.3±9.2 ng/ml; p<0.001. FF from 40 and 74 biopsied blastocysts was analysed of which 52.5 and 60.8% were euploid (p = 0.428), respectively. In VitD deficient patients, mean 25(OH)D-FF, bioavailable 25(OH)D-FF, and free 25(OH)D-FF were higher in euploid vs aneuploid blastocysts (18.3±6.3 ng/ml vs 13.9±4.8 ng/ml; p = 0.040; 1.5±0.5 ng/ml vs 1.1±0.4 ng/ml; p = 0.015; 0.005±0.002 ng/ml vs 0.003±0.001 ng/ml; p = 0.023, respectively), whilst no differences were found in VitD non-deficient patients (37.9±12.3 ng/ml vs 40.6±13.7 ng/ml; p = 0.380; 3.1±1.1 ng/ml vs 3.3±1.2 ng/ml; p = 0.323; 0.01±0.003 ng/ml vs 0.01±0.004 ng/ml; p = 0.319, respectively). Conclusion: VitD non-deficient patients have a significantly higher probability of obtaining a euploid blastocyst compared to VitD deficient patients (OR:33.36, p = 0.002).

Indexed as

AdultAneuploidyBlastocystFemaleFertilization in VitroFollicular FluidHumansHydroxycholecalciferolsInfertility, FemaleNutritional StatusOvulation InductionProspective StudiesVitamin DVitamin D DeficiencyHydroxycholecalciferolsVitamin D25(OH)Dbioavailable 25(OH)Dfollicular fluid% free 25(OH)Dfree 25(OH)DPGT-A

Identifiers

PMID33584542
PMCPMC7874043
OpenAlexW3123156674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.